dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Soosaipillai, Gehan |
dc.contributor.author | Wu, Anjui |
dc.contributor.author | Dettorre, Gino M |
dc.contributor.author | Diamantis, Nikolaos |
dc.contributor.author | Chester, John |
dc.contributor.author | Moss, Charlotte |
dc.contributor.author | Aguilar Company, Juan |
dc.contributor.author | Ruiz Camps, Isabel |
dc.contributor.author | Cabirta Touzon, Alba |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Saoudi Gonzalez, Nadia |
dc.date.accessioned | 2022-05-02T12:36:46Z |
dc.date.available | 2022-05-02T12:36:46Z |
dc.date.issued | 2021-09-02 |
dc.identifier.citation | Soosaipillai G, Wu A, Dettorre GM, Diamantis N, Chester J, Moss C, et al. Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective. Ther Adv Med Oncol. 2021 Sep 2;13:1-17. |
dc.identifier.issn | 1758-8359 |
dc.identifier.uri | https://hdl.handle.net/11351/7430 |
dc.description | COVID-19; Càncer; Cures al final de la vida |
dc.description.sponsorship | The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Wellcome Trust Strategic Fund [PS3416] awarded to DJP and by direct project funding from the NIHR Imperial Biomedical Research Centre (BRC) awarded to DJP. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. OnCovid was supported in part by funds from the Cancer Treatment and Research Trust (CTRT) awarded to DJP and from the Associazione Italiana per la Ricerca sul Cancro Foundation [14230] awarded to AG. |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Therapeutic Advances in Medical Oncology;13 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | COVID-19 (Malaltia) |
dc.subject | Tractament pal·liatiu |
dc.subject.mesh | Hospice Care |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /therapy |
dc.title | Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/17588359211042224 |
dc.subject.decs | cuidados paliativos al final de la vida |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | neoplasias |
dc.subject.decs | /terapia |
dc.relation.publishversion | https://doi.org/10.1177/17588359211042224 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Soosaipillai G] Cancer Division, University College London Hospitals, London, UK. [Wu A] Cancer Division, University College London Hospitals, London, UK UCL Cancer Institute, Fitzrovia, London, UK. [Dettorre GM] Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. [Diamantis N] Medical Oncology, Barts Health NHS Trust, London, UK. [Chester J] Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK. Medical Oncology, Velindre Cancer Centre, Cardiff, UK. [Moss C] Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK. [Aguilar-Company J] Servei d’Oncologia Mèdica, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Saoudi N, Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Cabirta A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34497669 |
dc.identifier.wos | 000697410800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |